First Trust Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,709
Closed -$1.48M 2417
2023
Q3
$1.48M Buy
+30,709
New +$1.82M ﹤0.01% 1815
2023
Q2
Sell
-21,108
Closed -$1.02M 2428
2023
Q1
$1.02M Sell
21,108
-41,288
-66% -$2.18M ﹤0.01% 1956
2022
Q4
$3.76M Buy
62,396
+23,588
+61% +$1.38M ﹤0.01% 1357
2022
Q3
$2.35M Sell
38,808
-4,907
-11% -$155K ﹤0.01% 1616
2022
Q2
$1.19M Sell
43,715
-5,352
-11% -$157K ﹤0.01% 1921
2022
Q1
$1.79M Sell
49,067
-28,081
-36% -$1.01M ﹤0.01% 1815
2021
Q4
$3.81M Buy
+77,148
New +$4.28M ﹤0.01% 1510
2018
Q1
Sell
-26,285
Closed -$985K 2361
2017
Q4
$985K Buy
26,285
+23,018
+705% +$1.17M ﹤0.01% 1851
2017
Q3
$212K Buy
+3,267
New +$200K ﹤0.01% 2313

Other funds holding PRTA

First Trust Advisors's PRTA Position: Q4 2023 in Review

First Trust Advisors sold out of Prothena Corp (PRTA) in Q4 2023, closing a stake of 30,709 shares — an estimated $1.48M sold.

First Trust Advisors first reported a position in PRTA in Q3 2017 and held it in 9 quarters. The position peaked at $3.81M in Q4 2021. 187 funds tracked by Wall St. Rank hold PRTA as of Q4 2023.

  • First Trust Advisors reported no remaining Prothena Corp position as of Q4 2023 after selling out during the quarter.
  • First Trust Advisors sold 30,709 Prothena Corp shares in Q4 2023, an estimated $1.48M.
  • First Trust Advisors first reported a position in Prothena Corp in Q3 2017 and held it in 9 quarters.
  • First Trust Advisors's Prothena Corp position peaked at $3.81M in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2023.

Based on First Trust Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.